Heart Failure Online 2022 On-demand
Published: 09 May 2022
Part 2 | Session 5 Session 2.5 - Practical Theory and Hot Topics
Part 3 | Session 2 Session 3.2 - Practical Theory and Hot Topics
Part 3 | Session 3 Session 3.3 - Live CRT Case
Part 3 | Session 4 Symposium - Making Gains in HFpEF: An Appraisal of Where We Are Now
Part 1 | Session 1 Session 1:1 - Patient Case: The Complex Patient Andrew JS Coats, Shelley Zieroth, Carolyn Lam, Ewa Jankowska, Ileana L Piña
Part 1 | Session 2 Session 1.2 - Practical Theory and Hot Topics Andrew JS Coats, Shelley Zieroth, Javed Butler, Ewa Jankowska, Carolyn Lam, Ileana L Piña
Part 1 | Session 3 Session 1.3 - Patient Case Revisited: Transitioning Care and Monitoring Technology Ileana L Piña, Philipp Lurz, Loreena Hill, Harriette Van Spall, Rajiv Sankaranarayanan
Part 1 | Session 4 Session 1.4 - Practical Theory and Hot Topics Ileana L Piña, Philipp Lurz, Loreena Hill, Harriette Van Spall, Rajiv Sankaranarayanan
Part 1 | Session 5 Symposium - The 2022 ACC Heart Failure Guidelines: What Do They Mean for Your Practice? Andrew JS Coats, Biykem Bozkurt, Mikhail Kosiborod
Part 2 | Session 1 Session 2.1 - Patient Case: HF Aetiology Ileana L Piña, Shelley Zieroth, Biykem Bozkurt, Fabien Praz
Part 2 | Session 2 Session 2.2 - Live MitraClip Case Ileana L Piña, Ralph Stephan von Bardeleben, Shelley Zieroth, Biykem Bozkurt, Fabien Praz
Heart Failure Online (HFO) is a new innovative virtual event, that brings together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.
With patient management and outcomes at its core, Course Director Prof Andrew Coats (President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK) leads an interactive programme of discussion, opinion and case studies focusing on the patient journey.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
Following the activities, participants will be able to:
- Select foundational and advanced management strategies in complex patients
- Discuss the validity of using ejection fraction to determine optimal treatment strategies
- Assess the likely impact of health technology on future practice
- Identify the underlying causes of heart failure
- Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
- Assess the impact of the multidisciplinary team on heart failure outcomes
- Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Day One: Individualising Treatment
Day Two: Complex Phenotypes and Advanced Treatment
Day Three: Beyond Foundational Management
Ileana L Piña
Dr Ileana L Pina is Professor at the Department of Medicine (Cardiology) and Professor in the Department of Epidemiology and Population Health at Montefiore Einstein Center for Heart and Vascular Care, US.
Dr Piña has a particular research and clinical interest in rehabilitation of heart disease in patients with heart failure. She completed a NHLBI HF ACTION trial and is in the process of examining recovery after exercise which could be translated to an additional parameter that may better predict prognosis of outcomes. In addition, there was a R21 to NHLBI to examine Vitamin D levels as another predictor from the HF ACTION database.
Dr Ileana L Pina is an Editorial Board member of Cardiac Failure Review.
Maria Generosa Crespo-Leiro
Shelley A Hall
Dr Shelley Hall is Chief of Transplant Cardiology and Mechanical Support/Heart Failure, Baylor University Medical Center, US. Dr Hall's particular focus is advanced heart failure and cardiac transplant. Under Dr Hall's direction as Chief of Transplant Cardiology, Mechanical Circulatory Support and Heart Failure, the programme has grown to be the largest in Texas and among the largest in the US. Her core clinical interests include percutaneous support of cardiogenic shock and minimization of testing in cardiac transplant.
Dr Alanna Morris is Assistant Professor of Medicine at the Department of Medicine, Emory University School of Medicine, US. Dr Morris' research interests include studying the importance of non-modifiable risk factors such as race and gender that may contribute to excess disease in high risk populations, and identifying the role of biomarkers of oxidative stress and endothelial dysfunction in patients with heart failure with reduced ejection fraction.
Joyce W. Wald
Dr Joyce W Wald is a cardiologist in Philadelphia, Pennsylvania, US, and is affiliated with multiple hospitals in the area, including Good Shepherd Penn Partners Speciality Hospital at Rittenhouse and Hospitals of the University of Pennsylvania-Penn Presbyterian. She received her medical degree from Philadelphia College of Osteopathic Medicine and has been in practice for more than 20 years.